Rhenman & Partners Asset Management Ab Portfolio Holdings

Rhenman & Partners Asset Management Ab

  • $854 Million
  • Q3 2025

Rhenman & Partners Asset Management Ab has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $854 Million distributed in 92 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $42.8M, Eli Lilly & CO with a value of $40.8M, Abb Vie Inc. with a value of $30.2M, Danaher Corp with a value of $26.7M, and Alignment Healthcare, Inc. with a value of $25.8M.

Examining the 13F form we can see an increase of $88.1M in the current position value, from $766M to 854M.

Rhenman & Partners Asset Management Ab is based out at Stockholm, V7

Below you can find more details about Rhenman & Partners Asset Management Ab portfolio as well as his latest detailed transactions.

Portfolio value $854 Million
Healthcare: $854 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 92
  • Current Value $854 Million
  • Prior Value $766 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 13, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 13 stocks
  • Additional Purchases 46 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 23 stocks
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email